SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-22-019154
Filing Date
2022-05-20
Accepted
2022-05-20 19:55:00
Documents
1
Period of Report
2022-05-19

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 3800
  Complete submission text file 0000899243-22-019154.txt   5116
Mailing Address 12 GILL STREET SUITE 4650 WOBURN MA 01801
Business Address 12 GILL STREET SUITE 4650 WOBURN MA 01801 617.871.2101 EXT 313
Comera Life Sciences Holdings, Inc. (Issuer) CIK: 0001907685 (see all company filings)

IRS No.: 000000000
SIC: 2834 Pharmaceutical Preparations

Mailing Address 12 GILL STREET SUITE 4650 WOBURN MA 01801
Business Address
Wexler William A. (Reporting) CIK: 0001927975 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41403 | Film No.: 22949302